Cannabis Rescheduled: TRUMP did WHAT? скачать в хорошем качестве

Cannabis Rescheduled: TRUMP did WHAT?

For over 50 years Cannabis has been classified as a Schedule I drug - which means it was as serious as Heroin. Of course, this is ridiculous but that is how America dealt with Marijuana...until now. And the man the made marijuana less serious, Trump? I didn't see this happening! For more videos like this, please subscribe. www.washdui.com Cannabis was placed in Schedule I of the Controlled Substances Act when Congress enacted the legislation in 1970, a decision made with very little medical or scientific evidence justifying the classification. Schedule I designation requires three criteria: high potential for abuse, no currently accepted medical use, and lack of accepted safety under medical supervision. The Act relegated marijuana to Schedule I, placing it alongside heroin, LSD, and other toxic pharmaceuticals as among the most dangerous and medically useless drugs. Ironically, the Shafer Commission, established by the same 1970 Act to study cannabis, recommended decriminalization in 1972, stating the criminal law was "too harsh a tool to apply to personal possession". The Nixon administration took no action to implement this recommendation, and cannabis has remained Schedule I for over five decades. This classification has profoundly harmed cannabis understanding and research. Clinical trials are expensive, and pharmaceutical companies are unlikely to invest in trials for naturally occurring substances they cannot patent. The stringent restrictions created what one expert called "strange incentives and disincentives" that pushed companies toward synthetic alternatives rather than studying natural cannabis. While scientists can conduct clinical trials, the approval process is unduly onerous, requiring protocols approved by the U.S. Attorney General and sourcing from federally licensed vendors—restrictions unique to marijuana among Schedule I substances. The Schedule I classification was fundamentally incorrect given cannabis's medical potential. The FDA has approved Epidiolex, containing CBD derived from marijuana, for treating seizures associated with rare forms of epilepsy—the first FDA-approved drug containing purified cannabis-derived substances. FDA has also approved drugs containing synthetic THC (Marinol, Syndros) and synthetic substances structurally similar to THC (Cesamet). These approvals directly contradict Schedule I's requirement of "no currently accepted medical use." By 2023, more than 35 jurisdictions had legalized medical marijuana, and there's been a huge cultural shift in understanding marijuana as having medicinal and social value. Recognition of this error led to HHS formally recommending in August 2023 that cannabis be reclassified to Schedule III, and President Trump issued an executive order in December 2025 directing the Attorney General to expeditiously move marijuana to Schedule III. #cannabisschedulei #cannabisscheduleiii